Skip to main content
. 2016 Jun;176:63–69. doi: 10.1016/j.ahj.2016.01.016

Table III.

Five-year absolute excess risk under hypothetical relative risks shown in Table II

5-y event rate in control group Hypothetical relative risk associated with allocation to statin therapy
1.05
1.1
1.2
1.3
Absolute difference in event rate associated with risk ratio
2% 0.1% 0.2% 0.4% 0.6%
5% 0.25% 0.5% 1.0% 1.5%
10% 0.5% 1.0% 2.0% 3.0%
20% 1.0% 2.0% 4.0% 6.0%